![Christopher Parker](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Christopher Parker served as the Managing Director for Roche Diagnostics Ltd. from 2012 to 2017 and later as the Executive Director for AnteoTech Ltd. from 2022 to 2023.
He received his undergraduate degree from Queensland University of Technology.
Eerdere bekende functies van Christopher Parker
| Bedrijven | Functie | Einde |
|---|---|---|
| ANTEOTECH LIMITED | Algemeen Directeur | 01-12-2019 |
Roche Diagnostics Ltd.
 Roche Diagnostics Ltd. Medical SpecialtiesHealth Technology Develops diagnostic tests and instruments | Corporate Officer/Principal | 01-07-2017 |
Opleiding van Christopher Parker
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
5
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Queensland University of Technology
 Queensland University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AnteoTech Ltd.
 AnteoTech Ltd. Medical SpecialtiesHealth Technology Develops, manufactures and commercializes proprietary surface coatings for health care & life sciences | Health Technology |
Roche Diagnostics Ltd.
Roche Diagnostics Ltd. Medical SpecialtiesHealth Technology Develops diagnostic tests and instruments | Health Technology |
